Allspring Global Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
VPM
VCM
EC
Allspring Global Investments's JAZZ Position: Q1 2026 in Review
Allspring Global Investments reduced its Jazz Pharmaceuticals (JAZZ) stake by 80% in Q1 2026, selling an estimated $2.14M and leaving 3,034 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.
Allspring Global Investments first reported a position in JAZZ in Q4 2021 and has held it in 18 quarters since. The position peaked at $20.5M in Q4 2022. 573 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Allspring Global Investments held 3,034 shares of Jazz Pharmaceuticals worth $571K as of Q1 2026.
- Allspring Global Investments sold 12,234 Jazz Pharmaceuticals shares in Q1 2026, an estimated $2.14M.
- Jazz Pharmaceuticals made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1356 holding.
- Allspring Global Investments first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
- Allspring Global Investments's Jazz Pharmaceuticals position peaked at $20.5M in Q4 2022.
- 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.